Ran BP-6 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Ran BP-6, a protein involved in the Ran GTPase signaling pathway. Ran BP-6 is part of the Ran-binding protein family, which plays a crucial role in nucleocytoplasmic transport, the process by which molecules such as RNA and proteins are shuttled between the nucleus and the cytoplasm. Ran GTPases function as molecular switches that alternate between GTP-bound active and GDP-bound inactive states, controlling the transport of molecules across the nuclear envelope. Ran BP-6 is thought to modulate the activity of Ran GTPase by binding to it, influencing its ability to regulate key processes such as RNA export, protein import, and mitotic spindle assembly during cell division. Inhibitors of Ran BP-6 typically work by blocking its interaction with Ran GTPase or interfering with its ability to participate in the transport cycle, effectively disrupting its regulatory role in nucleocytoplasmic trafficking.
The inhibition of Ran BP-6 can lead to significant changes in cellular processes that rely on efficient nucleocytoplasmic transport. By preventing Ran BP-6 from interacting with Ran GTPase, these inhibitors can impair the transport of critical macromolecules between the nucleus and cytoplasm, affecting functions such as gene expression, protein localization, and cell cycle progression. Researchers use Ran BP-6 inhibitors to explore the specific role of this protein in regulating nuclear transport and to understand how its inhibition impacts broader cellular activities, particularly those related to cell growth and division. These inhibitors also provide valuable insights into the complex regulatory mechanisms underlying nucleocytoplasmic transport and how Ran-binding proteins coordinate the dynamic exchange of molecules across the nuclear envelope. By studying Ran BP-6 inhibitors, scientists can gain a deeper understanding of the Ran GTPase signaling pathway and its importance in maintaining proper cellular function and organization.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibits the export of proteins from the nucleus by binding to exportin 1 (CRM1), which could alter Ran BP-6 function if it interacts with exportin 1. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
A broad-spectrum antiparasitic that can also potentiate the effect of the neurotransmitter GABA, causing paralysis in parasites. It disrupts nuclear transport by affecting importin α/β1 heterodimer. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
An endocrine disruptor that can interfere with cellular signaling pathways, potentially altering nuclear transport mechanisms involving Ran BP-6. | ||||||
Emodin | 518-82-1 | sc-202601 sc-202601A sc-202601B | 50 mg 250 mg 15 g | $105.00 $214.00 $6255.00 | 2 | |
A tyrosine kinase inhibitor that may interfere with signaling pathways and thus indirectly affect Ran BP-6 activity if it is regulated by tyrosine phosphorylation. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Inhibits Hsp90, which is involved in the proper folding of a variety of proteins; could affect Ran BP-6 if it requires Hsp90 for stability. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Binds to tubulin and prevents its polymerization, potentially affecting cell division and indirectly the function of Ran BP-6 in cell cycle progression. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Inhibits translation by binding to eIF4A, potentially decreasing the synthesis of proteins, including Ran BP-6. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Intercalates into DNA and disrupts DNA replication and RNA synthesis, possibly affecting Ran BP-6 levels if it is regulated at the transcriptional level. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules and blocks cell division, which could influence cellular processes where Ran BP-6 is a factor. | ||||||